Showing results (431-440 of 887) with videos related to

Sort By:
Pageof 89
Journal of Inherited Metabolic Disease|April 15, 2024
Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry diseaseAlexandra Klein, Katharina Klug, Maximilian Breyer, et al.
ESC Heart Failure|September 11, 2020
Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOMEPierpaolo Pellicori, Anne Pernille Ofstad, David Fitchett, et al.
Clinical Chemistry|March 11, 2017
Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D StudyVera Krane, Bernd Genser, Marcus E Kleber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 17, 2009
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltrationDetlef H Krieter, Andrea Hackl, Annie Rodriguez, et al.
Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2012
Vitamin D and cancer mortality: systematic review of prospective epidemiological studiesStefan Pilz, Katharina Kienreich, Andreas Tomaschitz, et al.
Cardiovascular Diabetology|April 1, 2021
Report from the CVOT Summit 2020: new cardiovascular and renal outcomesOliver Schnell, Xavier Cos, Francesco Cosentino, et al.
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
European Heart Journal Open|April 20, 2026
Intraepidermal nerve fiber density as a predictor of cardiac events in Fabry diseaseKolja Lau, Dan Liu, Victoria Sokalski, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2020
Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Kamlesh Khunti, David H Fitchett, et al.
Pageof 89